Polyrizon

Polyrizon Change in Working Capital

The Change in Working Capital of Polyrizon (PLRZ) as of Oct 22, 2026 is -158,000.00 USD. In the previous year, Change in Working Capital was -21,000.00 USD — a change of 652.38% (lower).

Change in Working Capital

-158,000.00USD

YoY

652.38%

Last updated:

Change in Working Capital of Polyrizon is 2025 -158,000.00 USD. Change in Working Capital of Polyrizon was 2024 -21,000.00 USD. It decreases by 652.38% lower compared to the previous year.

The Polyrizon Change in Working Capital history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Change in Working Capital
Date
Change in Working Capital
Jan 1, 2020
-1,000.00 USD
Jan 1, 2021
29,000.00 USD
Jan 1, 2022
-344,000.00 USD
Jan 1, 2023
7,000.00 USD
Jan 1, 2024
-21,000.00 USD
Jan 1, 2025
-158,000.00 USD
The Polyrizon Change in Working Capital history
YEARChange in Working CapitalYoY
-158,000.00USD+652.38%
-21,000.00USD-400.00%
7,000.00USD-102.03%
-344,000.00USD-1,286.21%
29,000.00USD-3,000.00%
-1,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polyrizon Stock analysis

What does Polyrizon do? Polyrizon Ltd develops medical device hydrogels delivered as nasal sprays that form a thin barrier in the nasal cavity to block viruses and allergens. The company specializes in creating a biological mask using naturally occurring building blocks, focusing on both product development and commercialization. Medical specialists and researchers collaborate with Polyrizon Ltd to advance their intranasal solutions. The firm's primary revenue comes from the development and commercialization of its nasal spray hydrogel products. These products target healthcare providers and consumers seeking protection against viral and allergen exposure. By forming a shield containment barrier, Polyrizon Ltd offers a solution that complements existing health measures without requiring additional equipment. Polyrizon Ltd's business model centers on the creation of a unique nasal barrier technology. The company leverages its focus on intranasal delivery to address market needs for non-invasive protection. Its collaboration with medical specialists ensures that its products meet clinical standards and user requirements. Polyrizon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Polyrizon stock

Change in Working Capital of Polyrizon is -158,000.00 USD in 2025.

Change in Working Capital of Polyrizon changed from -21,000.00 USD to -158,000.00 USD, representing a 652.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Change in Working Capital Polyrizon since 2006 – with annual values, charts, and detailed analysis.

Change in working capital reflects the period-over-period change in current assets minus current liabilities. It impacts operating cash flow significantly.

Change in Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Change in Working Capital's Polyrizon historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Polyrizon

All Key Metrics — Polyrizon